The Tumor-Platelet-Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation, and Therapeutic Vulnerabilities

Key Points

• To investigate the role of platelet-leukocyte crosstalk and NETosis in tumor metastasis and identify therapeutic vulnerabilities.
• Assessment of CTC survival and immune evasion mechanisms
• Evaluation of NETosis in metastatic progression
• Analysis of existing anti-platelet and anti-inflammatory therapies
• Development of multi-stimuli-responsive nanoparticles for targeted therapy
• Integration of platelet, immune, and tumor-targeting strategies
• Platelet-leukocyte interactions promote CTC survival and immune evasion.
• NETosis significantly enhances metastatic progression.
• Conventional therapies inadequately address the interconnected pathways involved.
• Novel nanoparticles can deliver treatments precisely and effectively.
• Multi-modal approaches can reduce metastatic seeding and disease progression.

Abstract